<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Med Sci</journal-id><journal-id journal-id-type="publisher-id">AMS</journal-id><journal-title-group><journal-title>Archives of Medical Science : AMS</journal-title></journal-title-group><issn pub-type="ppub">1734-1922</issn><issn pub-type="epub">1896-9151</issn><publisher><publisher-name>Termedia Publishing House</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22295029</article-id><article-id pub-id-type="pmc">3258739</article-id><article-id pub-id-type="publisher-id">AMS-7-3-457</article-id><article-id pub-id-type="doi">10.5114/aoms.2011.23412</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Predicting lymph node status in patients with early gastric carcinoma using double contrast-enhanced ultrasonography</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Nianyu</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Pintong</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aronow</surname><given-names>Wilbert S.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zongmin</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nair</surname><given-names>Chandra K.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Zhiqiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Xuedong</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Yimei</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Fuguang</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cosgrove</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>2<sup>nd</sup> Affiliated Hospital of Wenzhou Medical College, Zhejiang, China</aff><aff id="aff2"><label>2</label>Cardiology Division, New York Medical College, Valhalla, NY, USA</aff><aff id="aff3"><label>3</label>Cardiac Center of Creighton University, Omaha, NE, USA</aff><aff id="aff4"><label>4</label>Imaging Sciences Department, Imperial College, Hammersmith Hospital, London, United Kingdom</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Wilbert S. Aronow MD, Cardiology Division, New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, USA, Phone: 914-493-5311, Fax: 914-235-6274. E-mail: <email xlink:href="wsaronow@aol.com">wsaronow@aol.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>11</day><month>7</month><year>2011</year></pub-date><volume>7</volume><issue>3</issue><fpage>457</fpage><lpage>464</lpage><history><date date-type="received"><day>2</day><month>5</month><year>2010</year></date><date date-type="rev-recd"><day>29</day><month>5</month><year>2010</year></date><date date-type="accepted"><day>31</day><month>5</month><year>2010</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2011 Termedia &#x00026; Banach</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Double contrast-enhanced ultrasonography (DCUS) is a new method we used in predicting lymph node metastasis (LNM) in patients with early gastric cancer.</p></sec><sec><title>Material and methods</title><p>Seventy-six patients with early gastric cancer diagnosed by gastroscope and confirmed by pathology after operation were examined using DCUS preoperatively. Group N1 included 15 patients with LNM and group N0 61 patients without LNM.</p></sec><sec><title>Results</title><p>In group N1, 13 patients (87%) had marked hyperenhancement during early arterial phase using DCUS, and 2 patients (13%) were unmarked as hyperenhancement. In group N0, 24 patients (39%) had marked hyperenhancement during early arterial phase using DCUS, and 37 patients (61%) had unmarked hyperenhancement. The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer was 86.7% and 60.7% respectively, and the Youden&#x02019;s index was 0.474. The &#x003ba; value of this method was 0.89.</p></sec><sec><title>Conclusions</title><p>Double contrast-enhanced ultrasonography is a new valuable method to evaluate LNM at an early stage of gastric cancer and prognosis of early gastric cancer preoperatively.</p></sec></abstract><kwd-group><kwd>early gastric cancer</kwd><kwd>lymph node metastasis</kwd><kwd>contrast-enhanced ultrasonography</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>As a result of increased diagnostic accuracy and the wider application of mass surveys, the proportion of early gastric cancer (EGC) among resected gastric cancers has steadily increased, not only in Asia, but also in some Western countries [<xref ref-type="bibr" rid="R1">1</xref>-<xref ref-type="bibr" rid="R6">6</xref>]. Although the prognosis of EGC is excellent [<xref ref-type="bibr" rid="R7">7</xref>-<xref ref-type="bibr" rid="R9">9</xref>], EGC with lymph node metastasis (LNM) has a higher possibility of recurrence [<xref ref-type="bibr" rid="R10">10</xref>-<xref ref-type="bibr" rid="R12">12</xref>]. Because the presence of LNM is the most important prognostic factor for patients with EGC [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R13">13</xref>-<xref ref-type="bibr" rid="R15">15</xref>], radical surgery with extended (D2) lymph node dissection (LND) has become the gold standard treatment for patients with EGC [<xref ref-type="bibr" rid="R16">16</xref>-<xref ref-type="bibr" rid="R19">19</xref>].</p><p>The prevalence of LNM in EGC ranges from 10% to 20% [<xref ref-type="bibr" rid="R20">20</xref>-<xref ref-type="bibr" rid="R24">24</xref>]. Therefore, at least 80% of patients will undergo unnecessary surgery with D2 lymphadenectomy [<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>]. Bonenkamp <italic>et al</italic>. [<xref ref-type="bibr" rid="R27">27</xref>] reported that patients with D2 lymph node resection have a higher operative mortality rate with more complications and a longer postoperative hospital stay. Recently, various minimally invasive procedures such as endoscopic mucosal resection and laparoscopic wedge resection without LND have been performed in selected EGC patients to improve the quality of life of long-term survivors [<xref ref-type="bibr" rid="R28">28</xref>-<xref ref-type="bibr" rid="R35">35</xref>]. For such procedures, the accurate prediction of LNM is crucial to determining the extent of LND.</p><p>Although it is extremely useful to know the involvement of lymph nodes before surgery, there is no simple and high sensitivity test to evaluate lymph node status preoperatively. Diagnostic imaging techniques including endoscopic ultrasound (EUS), computed tomography (CT), positron emission tomography (PET) and ultrasonography (US) are still unsatisfactory and do not provide enough evidence for an accurate prediction of metastasis in the regional lymph nodes draining gastric cancer because of their low sensitivity [<xref ref-type="bibr" rid="R36">36</xref>-<xref ref-type="bibr" rid="R41">41</xref>]. It is also difficult to diagnose such nodes during operation [<xref ref-type="bibr" rid="R42">42</xref>]. Because direct detection of LNM with high sensitivity is impossible yet, the indirect assessment of LNM in EGC is still based on the pathobiologic behaviors of the tumor [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R43">43</xref>]. Accurate assessment of the pathobiologic behaviors of the tumor needs resected specimens. Biopsies are too superficial to provide the entire information of the tumor [<xref ref-type="bibr" rid="R13">13</xref>].</p><p>Conventional trans-abdominal US has been considered unsuitable for the detection of early staging lesions and LNM [<xref ref-type="bibr" rid="R44">44</xref>]. Oral contrast agent assisted US has been widely used to detect gastric cancer in China. In the present study, we sought to assess LNM of EGC preoperatively using double contrast-enhanced ultrasonography (DCUS), an oral ultrasonic contrast agent combined with an intravenous contrast agent.</p></sec><sec sec-type="materials|methods"><title>Material and methods</title><p>Eighty patients with EGC proven by pathology were examined with DCUS preoperatively between 2005 and 2009 after obtaining written informed consent. Of the 79 patients, 3 were excluded, one with advanced gastric cancer and the other 2 with the number of retrieved lymph nodes less than 15. The remaining 76 patients were enrolled in this study. The mean age of the patients was 58.3 years (range 35-83). The male to female ratio was 1.71 (48/28). Written informed consent was obtained from all patients. The ethics committee for our institution approved the study.</p><p>In this study, all patients underwent curative gastrectomy with D2 or more extended (D3) lymphadenectomy for primary early GC. Surgical resections were performed within 3 to 5 days after the DCUS examination. None of the patients in this study received nonsteroidal anti-inflammatory drugs, chemotherapy, radiotherapy, or immunotherapy before surgery. All of the subjects were divided into 2 groups according to their lymph nodes status postoperatively. Group N1 included 15 patients with LNM. Group N0 included 61 patients without LNM.</p><p>Double contrast-enhanced ultrasonography was performed after fasting for at least 6 h; Atropine sulfate injection (0.05 mg/kg) was administered via intramuscular injection half an hour before the examination to inhibit gastric peristalsis. An Acuson Sequoia 512 system (Siemens, Mountain View, CA), equipped with a 4V1 vector&#x02122; transducer (frequency: 1.0~4.0 MHz) and contrast pulse sequencing (CPS) technology with auto-tracking contrast quantification (ACQ) software was used (Phillips and Gardner 2004).</p><p>The oral contrast agent Xinzhang&#x000ae; (Huqingyutang, HangZhou, China) was supplied as a microdot powder which was composed of a kind of soya derivative (48 g per package); it was reconstituted by adding 500 ml of boiling water and gently agitating the water by hand to form a homogeneous particulate suspension.</p><p>The distal esophagus of all patients was observed dynamically while the patients ingested the oral ultrasonic agent to expand the stomach and evacuate the air in stomach. Hence, the stomach lumen appeared as an iso-echoic homogenous acoustic window. Then the other parts of the stomach and the duodenal bulb were examined in turns with the patient in different body positions. When a suspected lesion was identified, it was measured routinely. If the lesion was smaller than 5 cm, it would be zoomed in for higher spatial resolution. Then after this procedure, a dynamic real-time contrast-enhanced sonography with CPS mode was performed using the following settings: insonating frequency 1.5 MHz and acoustic power, &#x02013;15 to &#x02013;21 dB. A low mechanical index (0.20) was selected to minimize microbubble disruption. Images of the ideal scanning plane were displayed in a real-time fashion by slightly changing the scanning plane to portray the whole area of the tumor.</p><p>Contrast-enhanced sonographic studies were performed after the administration of 2.4 ml of SonoVue (Bracco SpA, Milan, Italy) as a bolus via a 19-gauge peripheral intravenous cannula. The cannula was flushed with 10 ml saline. A timer on the sonography unit was activated at the beginning of injection, and the entire movie sequence (at least 5 min) was stored on magnetic optical disks for analysis. The contrast study could be repeated a second time if necessary.</p><p>The cine loops of the 69 lesions were retrospectively reviewed by 2 independent radiologists who are experts in sonography and microbubble contrast agents. Vascular enhancement of gastric carcinomas was visually classified into 3 patterns: hyper- enhancement, iso-enhancement, and hypo-enhancement. Hyper- enhancement was defined as a signal intensity over the whole tumor higher than the adjacent normal gastric wall during the whole arterial phase. Iso-enhancement was defined as a signal intensity over the whole tumor similar to the adjacent normal gastric wall during the whole arterial phase. Hypo-enhancement was defined as a signal intensity over the whole tumor lower than the adjacent normal gastric wall during the whole arterial phase. According to the pattern of enhancement, all cases were classified into the marked hyperenhancement group and the unmarked hyperenhancement group (including hypoenhancement and isoenhancement). The 2 reviewers were unaware of the definitive diagnosis and other imaging information at the time of the analysis. Double contrast-enhanced ultrasonography diagnoses were then compared with the final diagnosis based on the pathologic results.</p><p>Lymph nodes were meticulously dissected from the en bloc specimens, and the classification of the dissected lymph nodes was determined by surgeons who reviewed the excised specimens after surgery based on the Japanese Classification of Gastric Carcinoma. The primary tumor and retrieved lymph nodes were fixed in 10% formaldehyde solution, embedded in paraffin, incised into 4 mm sections, and mounted on poly-lysine-coated slides. These sections were stained by hematoxylin-and-eosin method to confirm their histological diagnosis and other microscopic characteristics. Experienced pathologists were employed to ensure a high quality of pathological diagnosis. The following clinicopathologic variables were evaluated: sex, age, location of tumor (lower third, middle third, upper third, or entire stomach), tumor diameter, histological type (differentiated: well differentiated, moderately differentiated, or papillary; undifferentiated: poorly differentiated, signet-ring cell, or mucinous), LNM, and depth of invasion (mucosa or submucosa).</p><p>Sensitivity, specificity and Youden&#x02019;s index were calculated for both oral contrast-enhanced ultrasonography and DCUS. Statistical evaluation was performed using the &#x003c7;<sup>2</sup> test or Fisher&#x02019;s exact test to differentiate the rates among the different groups. Student&#x02019;s <italic>t</italic>-test was used to analyze quantitative data. Kappa statistics was used to show the level of correlation in agreement between the 2 reviewers. Kappa values are categorized as follows [<xref ref-type="bibr" rid="R45">45</xref>]. Values between &#x02013;1 and 0 indicate "no agreement"; between 0 and 0.20 indicate "poor agreement"; between 0.21 and 0.40 indicate "slight agreement"; between 0.41 and 0.60 indicate "fair agreement"; between 0.61 and 0.80 indicate "good agreement"; between 0.81 and 0.90 indicate "very good agreement"; and between 0.91 and 1.0 indicate "excellent agreement". For all analyses, a <italic>p</italic> value of less than 0.05 was considered statistically significant. All data were analyzed using SPSS13.0 statistical software (Chicago, IL, United States).</p></sec><sec><title>Results</title><p>A total of 76 patients who had undergone gastrectomy with D2 or more extended (D3) lymphadenectomy for EGC at the 2<sup>nd</sup> Affiliated Hospital of Wenzhou Medical College were studied. The number of retrieved lymph nodes in all patients was more than 15, ranging from 15 to 63 (median, 29.9). Lymph node metastasis was detected in 15 patients (19.7%), and the number of metastatic lymph nodes ranged from 1 to 36 (median 6.9).</p><p>In group N1, 13 patients (87%) had marked hyperenhancement compared with the adjacent normal gastric wall during the early arterial phase by using DCUS (Figure <xref ref-type="fig" rid="F1">1 C</xref>), and the other 2 patients (13%) had unmarked hyperenhancement. However, in group N0, 24 patients (39%) had marked early hyperenhancement compared to the adjacent normal gastric wall during the arterial phase using DCUS, and the other 37 patients had unmarked hyperenhancement (Figure <xref ref-type="fig" rid="F2">2 C</xref>). The sensitivity and specificity of marked hyperenhancement in predicting LNM in patients with early gastric cancer were 86.7% and 60.7%, respectively, and the Youden&#x02019;s index was 0.474 (Table <xref ref-type="table" rid="T1">I</xref>). The relationships between pathological characteristics of patients and the type of contrast enhancement are summarized in Table <xref ref-type="table" rid="T2">II</xref>.</p></sec><sec><title>Discussion</title><p>Since LNM remains one of the most important predictors for survival, reduction in lymphadenectomy will probably result in a residue of metastatic lymph nodes [<xref ref-type="bibr" rid="R19">19</xref>]. Unnecessarily extended resection will induce a series of complications, which also result in a poor quality of life [<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>]. Thus, it is important to standardize the optimal extent of LND by investigating LNM of EGC preoperatively.</p><p>The low sensitivities of EUS, CT, US and PET are insufficient to allow decision making on the extent of lymphadenectomy [<xref ref-type="bibr" rid="R37">37</xref>-<xref ref-type="bibr" rid="R40">40</xref>]. Endoscopic ultrasound, MR and CT mainly depend on lymph node size as criteria to define malignancy [<xref ref-type="bibr" rid="R48">48</xref>]. Lymph nodes of less than 5 mm in diameter cannot be accurately detected by available imaging techniques [<xref ref-type="bibr" rid="R49">49</xref>-<xref ref-type="bibr" rid="R51">51</xref>]. In one study, 55% of the metastatic lymph nodes were 5 mm or less in diameter [<xref ref-type="bibr" rid="R52">52</xref>]. The lack of correlation between lymph node size and metastatic infiltration has been reported in studies of other solid tumors [<xref ref-type="bibr" rid="R53">53</xref>-<xref ref-type="bibr" rid="R57">57</xref>]. Therefore, differentiating between benign and metastatic lymph nodes may be unreliable when lymph node size is used as a criterion [<xref ref-type="bibr" rid="R52">52</xref>]. Lymph node metastasis of EGC is still predicted by means of the presence or absence of certain tumor characteristics postoperatively [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R43">43</xref>, <xref ref-type="bibr" rid="R58">58</xref>].</p><p>It is very difficult for conventional transabdominal US to visualize the gastric cancer without any assistant because of the interference of gas in the stomach (Figures <xref ref-type="fig" rid="F1">1 A</xref>, <xref ref-type="fig" rid="F2">2 A</xref>). Although the likelihood of detecting gastric cancer followed by oral contrast agent exist (Figures <xref ref-type="fig" rid="F1">1 B</xref>, <xref ref-type="fig" rid="F2">2 B</xref>), the sensitivity of diagnosis of LNM of EGC by oral contrast-enhanced ultrasonography is still very low (Figure <xref ref-type="fig" rid="F1">1 B</xref>), with a rate of 33.3% in our study.</p><p>Double contrast-enhanced ultrasonography could be considered as a valid method to evaluate the microcirculatory perfusion of gastric cancer using intravenous contrast agents, based on taking an oral ultrasonic agent. An oral ultrasonic agent which was composed by a kind of soya derivative has some contribution for this study, such as the how to evacuate the air in stomach and distend the gastric lumen for displaying the lesions prominently. After taking the oral contrast agent, the stomach lumen appeared as an iso-echoic homogenous acoustic window, and its effect was superior to water because the evacuation was slow. SonoVue, a microbubble contrast material with a mean diameter of 2.5 &#x000b5;m, is a blood pool agent that does not cross into the interstitial space [<xref ref-type="bibr" rid="R59">59</xref>, <xref ref-type="bibr" rid="R60">60</xref>].</p><p>Because such microbubbles flow with red blood cells, the injected microbubbles act as markers for tissues that are densely populated with vessels, thereby, suggesting that angiogenesis is the foundation for tumor enhancement [<xref ref-type="bibr" rid="R61">61</xref>, <xref ref-type="bibr" rid="R62">62</xref>]. Angiogenesis is important for tumor growth and metastasis [<xref ref-type="bibr" rid="R63">63</xref>-<xref ref-type="bibr" rid="R65">65</xref>]. Angiogenesis is an unfavorable factor related to LNM in EG [<xref ref-type="bibr" rid="R66">66</xref>]. Double contrast-enhanced ultrasonography can be used to assess vascularity and the biological behavior of gastric carcinomas <italic>in vivo</italic> [<xref ref-type="bibr" rid="R67">67</xref>].</p><p>Because of this finding, we sought to predict the LNM in EGC preoperatively using DCUS by means of certain primary tumor characteristics. Although the specificity decreased from 98.4% with oral contrast-enhanced ultrasonography to 60.7% with DCUS (<italic>p</italic> &#x0003c; 0.005), the sensitivity was improved from 33.3% with oral contrast-enhanced ultrasonography to 86.7% with DCUS (<italic>p</italic> &#x0003c; 0.005). Because the presence of LNM has a strong adverse influence on the prognosis of patients with EGC [<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R22">22</xref>, <xref ref-type="bibr" rid="R68">68</xref>-<xref ref-type="bibr" rid="R70">70</xref>], the high sensitivity of diagnosis is more important. The agreement of this diagnosis is very good (&#x003ba; value = 0.89).</p><p>Intratumor microvessel density (MVD) is a reliable index of tumor angiogenesis [<xref ref-type="bibr" rid="R71">71</xref>]. Many previous studies of gastric carcinoma have demonstrated that angiogenesis is one of the crucial factors for tumor development and progression in gastric cancer [<xref ref-type="bibr" rid="R72">72</xref>, <xref ref-type="bibr" rid="R73">73</xref>]. Angiogenesis is closely correlated with biological behaviors, degree of differentiation, and metastatic lymphadenopathy in gastric cancer [<xref ref-type="bibr" rid="R74">74</xref>]. Contrast-enhanced intensity has a strong positive linear correlation with MVD in gastric carcinoma [<xref ref-type="bibr" rid="R67">67</xref>]. Therefore, contrast-enhanced intensity is a promising index to evaluate the growth and progression of gastric carcinoma. This study demonstrates that depth of tumor size and degree of differentiation both relate to contrast-enhanced intensity (<italic>p</italic> &#x0003c; 0.05), which indicates that contrast-enhanced intensity can be used to assess the biological behavior of EGC <italic>in vivo</italic>. We found that degree of differentiation was significantly associated with LNM (<italic>p</italic> &#x0003c; 0.05), similar to that indicated by other authors [<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R75">75</xref>].</p><p>Although contrast enhanced ultrasonography can assess whether LNM is present in the patients with DCUS, the location and number of lymph nodes cannot be determined. Further studies are required to evaluate LNM with precise quantitative analysis.</p><p>In conclusion, DCUS shows promise as a new noninvasive, convenient, and repeatable method to evaluate LNM in EGC and the prognosis of EGC preoperatively. Identification of EGC with marked hyperenhancement allows closer postoperative follow-up and possibly the use of drugs targeted for the growth of new vessels to prevent recurrence.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by grants from Science and Technology Bureau of Wenzhou, Zhejiang province, China, Foreign Cooperation Foundation (H20060039). We thank all the surgeons, pathologists and the technicians at the 2<sup>nd</sup> Affiliated Hospital of Wenzhou Medical College.</p></ack><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentsch</surname><given-names>HH</given-names></name><name><surname>Groitl</surname><given-names>H</given-names></name><name><surname>Giedl</surname><given-names>J</given-names></name></person-group><article-title>Results of surgical treatment of early gastric cancer in 113 patients</article-title><source>World J Surg</source><year>1981</year><volume>5</volume><fpage>103</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7233947</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>PH</given-names></name><name><surname>O&#x02019;Toole</surname><given-names>KM</given-names></name><name><surname>Weinberg</surname><given-names>LM</given-names></name><name><surname>Goldfarb</surname><given-names>JP</given-names></name></person-group><article-title>Early gastric cancer</article-title><source>Gastroenterology</source><year>1981</year><volume>81</volume><fpage>247</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">7239133</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochwald</surname><given-names>SN</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name><name><surname>Klimstra</surname><given-names>DS</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Karpeh</surname><given-names>MS</given-names></name></person-group><article-title>Is lymphadenectomy necessary for early gastric cancer?</article-title><source>Ann Surg Oncol</source><year>1999</year><volume>6</volume><fpage>664</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10560852</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>JD</given-names></name><name><surname>Tudway</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Superficial carcinoma of the stomach</article-title><source>Br Med J</source><year>1976</year><volume>2</volume><fpage>77</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1276819</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maehara</surname><given-names>Y</given-names></name><name><surname>Kakeji</surname><given-names>Y</given-names></name><name><surname>Oda</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>I</given-names></name><name><surname>Akazawa</surname><given-names>K</given-names></name><name><surname>Sugimachi</surname><given-names>K</given-names></name></person-group><article-title>Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer</article-title><source>Br J Cancer</source><year>2000</year><volume>83</volume><fpage>986</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10993643</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sue-Ling</surname><given-names>HM</given-names></name><name><surname>Martin</surname><given-names>I</given-names></name><name><surname>Griffith</surname><given-names>J</given-names></name><etal/></person-group><article-title>Early gastric cancer 46 cases treated in one surgical department</article-title><source>Gut</source><year>1992</year><volume>33</volume><fpage>1318</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">1446852</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>Y</given-names></name><name><surname>Saku</surname><given-names>M</given-names></name><name><surname>Kawanaka</surname><given-names>H</given-names></name><etal/></person-group><article-title>Prophylactic lymph node dissection for early gastric cancer invading submucosa</article-title><source>Hepatogastroenterology</source><year>2004</year><volume>51</volume><fpage>887</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">15143940</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roviello</surname><given-names>F</given-names></name><name><surname>Rossi</surname><given-names>S</given-names></name><name><surname>Marrelli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Number of lymph node metastases and its prognostic significance in early gastric cancer a multicenter Italian study</article-title><source>J Surg Oncol</source><year>2006</year><volume>94</volume><fpage>275</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">16917863</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Recurrence of early gastric cancer</article-title><source>Zhonghua Yi Xue Za Zhi</source><year>1996</year><volume>76</volume><fpage>750</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">9275516</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borie</surname><given-names>F</given-names></name><name><surname>Plaisant</surname><given-names>N</given-names></name><name><surname>Millat</surname><given-names>B</given-names></name><name><surname>Hay</surname><given-names>JM</given-names></name><name><surname>Fagniez</surname><given-names>PL</given-names></name></person-group><article-title>Appropriate gastric resection with lymph node dissection for early gastric cancer</article-title><source>Ann Surg Oncol</source><year>2004</year><volume>11</volume><fpage>512</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15078634</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Sasako</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name></person-group><article-title>Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature</article-title><source>Cancer</source><year>1993</year><volume>72</volume><fpage>3174</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8242540</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>K</given-names></name><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Shiraishi</surname><given-names>N</given-names></name><name><surname>Inomata</surname><given-names>M</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Kitano</surname><given-names>S</given-names></name></person-group><article-title>Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer</article-title><source>Ann Surg Oncol</source><year>2002</year><volume>9</volume><fpage>771</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12374660</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoda</surname><given-names>T</given-names></name><name><surname>Yanagisawa</surname><given-names>A</given-names></name><name><surname>Sasako</surname><given-names>M</given-names></name><etal/></person-group><article-title>Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers</article-title><source>Gastric Cancer</source><year>2000</year><volume>3</volume><fpage>219</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">11984739</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jentschura</surname><given-names>D</given-names></name><name><surname>Heubner</surname><given-names>C</given-names></name><name><surname>Manegold</surname><given-names>BC</given-names></name><name><surname>Rumstadt</surname><given-names>B</given-names></name><name><surname>Winkler</surname><given-names>M</given-names></name><name><surname>Trede</surname><given-names>M</given-names></name></person-group><article-title>Surgery for early gastric cancer a European one-center experience</article-title><source>World J Surg</source><year>1997</year><volume>21</volume><fpage>845</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9327676</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roder</surname><given-names>JD</given-names></name><name><surname>Bottcher</surname><given-names>K</given-names></name><name><surname>Busch</surname><given-names>R</given-names></name><name><surname>Wittekind</surname><given-names>C</given-names></name><name><surname>Hermanek</surname><given-names>D</given-names></name><name><surname>Siewert</surname><given-names>JR</given-names></name></person-group><article-title>Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group</article-title><source>Cancer</source><year>1998</year><volume>82</volume><fpage>621</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">9477092</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isozaki</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Okajima</surname><given-names>K</given-names></name></person-group><article-title>General and specific prognostic factors of early gastric carcinoma treated with curative surgery</article-title><source>Hepatogastroenterology</source><year>1999</year><volume>46</volume><fpage>1800</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10430349</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>kamura</surname><given-names>T</given-names></name><name><surname>Tsujitani</surname><given-names>S</given-names></name><name><surname>Korenaga</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis</article-title><source>Am J Surg</source><year>1988</year><volume>155</volume><fpage>476</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">3344913</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name></person-group><article-title>Clinicopathological features associated with lymph node metastasis in early gastric cancer analysis of a single-institution experience in China</article-title><source>Can J Gastroenterol</source><year>2009</year><volume>23</volume><fpage>353</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">19440566</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>YY</given-names></name><name><surname>Huang</surname><given-names>BJ</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>YP</given-names></name></person-group><article-title>Risk factors for lymph node metastasis and evaluation of reasonable surgery for early gastric cancer</article-title><source>World J Gastroenterol</source><year>2007</year><volume>13</volume><fpage>5133</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17876881</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guadagni</surname><given-names>S</given-names></name><name><surname>Reed</surname><given-names>PI</given-names></name><name><surname>Johnston</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Early gastric cancer followup after gastrectomy in 159 patients</article-title><source>Br J Surg</source><year>1993</year><volume>80</volume><fpage>325</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8472141</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanazaki</surname><given-names>K</given-names></name><name><surname>Wakabayashi</surname><given-names>M</given-names></name><name><surname>Sodeyama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Surgical outcome in early gastric cancer with lymph node metastasis</article-title><source>Hepatogastroenterology</source><year>1997</year><volume>44</volume><fpage>907</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">9222713</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JP</given-names></name><name><surname>Hur</surname><given-names>YS</given-names></name><name><surname>Yang</surname><given-names>HK</given-names></name></person-group><article-title>Lymph node metastasis as a significant prognostic factor in early gastric cancer analysis of 1 136 early gastric cancers</article-title><source>Ann Surg Oncol</source><year>1995</year><volume>2</volume><fpage>308</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">7552619</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maehara</surname><given-names>Y</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name><name><surname>Oshiro</surname><given-names>T</given-names></name><etal/></person-group><article-title>Early carcinoma of the stomach</article-title><source>Surg Gynecol Obstet</source><year>1993</year><volume>177</volume><fpage>593</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8266270</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranaldi</surname><given-names>R</given-names></name><name><surname>Santinelli</surname><given-names>A</given-names></name><name><surname>Verdolini</surname><given-names>R</given-names></name><name><surname>Rezai</surname><given-names>B</given-names></name><name><surname>Mannello</surname><given-names>B</given-names></name><name><surname>Bearzi</surname><given-names>I</given-names></name></person-group><article-title>Long-term follow-up in early gastric cancer evaluation of prognostic factors</article-title><source>J Pathol</source><year>1995</year><volume>177</volume><fpage>343</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">8568588</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyung</surname><given-names>WJ</given-names></name><name><surname>Cheong</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Noh</surname><given-names>SH</given-names></name></person-group><article-title>Application of minimally invasive treatment for early gastric cancer</article-title><source>J Surg Oncol</source><year>2004</year><volume>85</volume><fpage>181</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14991872</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Tsuburaya</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>O</given-names></name><name><surname>Sairenji</surname><given-names>M</given-names></name><name><surname>Motohashi</surname><given-names>H</given-names></name><name><surname>Noguchi</surname><given-names>Y</given-names></name></person-group><article-title>Indications of limited surgery for gastric cancer with submucosal invasion analysis of 715 cases with special reference to site of the tumor and level 2 lymph nodes</article-title><source>Hepatogastroenterology</source><year>2003</year><volume>50</volume><fpage>1727</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">14571828</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MF</given-names></name></person-group><article-title>Current status of surgery for gastric cancer a review</article-title><source>Gastric Cancer</source><year>2005</year><volume>8</volume><fpage>64</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">15864711</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>N</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Laparoscopic lymph node dissection after endoscopic submucosal dissection a novel and minimally invasive approach to treating early-stage gastric cancer</article-title><source>Am J Surg</source><year>2005</year><volume>190</volume><fpage>496</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">16105543</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez Rossell</surname><given-names>M</given-names></name></person-group><article-title>Endoscopic treatment of early gastric cancer: from endoscopic mucosal resection (EMR) to endoscopic submucosal dissection (ESD)</article-title><source>Rev Gastroenterol Peru</source><year>2005</year><volume>25</volume><fpage>76</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15818423</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoda</surname><given-names>T</given-names></name></person-group><article-title>A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer</article-title><source>Clin Gastroenterol Hepatol</source><year>2005</year><volume>3</volume><fpage>S71</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">16013003</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoda</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Soetikno</surname><given-names>RM</given-names></name></person-group><article-title>Endoscopic submucosal dissection of early gastric cancer</article-title><source>J Gastroenterol</source><year>2006</year><volume>41</volume><fpage>929</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17096062</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirasaki</surname><given-names>S</given-names></name><name><surname>Tanimizu</surname><given-names>M</given-names></name><name><surname>Nasu</surname><given-names>J</given-names></name><name><surname>Shinji</surname><given-names>T</given-names></name><name><surname>Koide</surname><given-names>N</given-names></name></person-group><article-title>Treatment of elderly patients with early gastric cancer by endoscopic submucosal dissection using an insulated-tip diathermic knife</article-title><source>Intern Med</source><year>2005</year><volume>44</volume><fpage>1033</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16293912</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Togashi</surname><given-names>A</given-names></name><name><surname>Inoue</surname><given-names>M</given-names></name><etal/></person-group><article-title>Indications for EMR/ESD in cases of early gastric cancer: relationship between histological type depth of wall invasion and lymph node metastasis</article-title><source>Gastric Cancer</source><year>2007</year><volume>10</volume><fpage>35</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17334716</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name></person-group><article-title>Endoscopic submucosal dissection (ESD) is being accepted as a new procedure of endoscopic treatment of early gastric cancer</article-title><source>Intern Med</source><year>2005</year><volume>44</volume><fpage>85</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15750264</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>H</given-names></name></person-group><article-title>Endoscopic submucosal dissection for early gastric cancer</article-title><source>Chin J Dig Dis</source><year>2005</year><volume>6</volume><fpage>119</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16045601</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akahoshi</surname><given-names>K</given-names></name><name><surname>Chijiiwa</surname><given-names>Y</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><etal/></person-group><article-title>Endoscopic ultrasonography a promising method for assessing the prospects of endoscopic mucosal resection in early gastric cancer</article-title><source>Endoscopy</source><year>1997</year><volume>29</volume><fpage>614</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9360870</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpert</surname><given-names>RD</given-names></name><name><surname>Feczko</surname><given-names>PJ</given-names></name></person-group><article-title>Role of radiology in the diagnosis and staging of gastric malignancy</article-title><source>Endoscopy</source><year>1993</year><volume>25</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">8453925</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumaier</surname><given-names>CE</given-names></name><name><surname>Cittadini</surname><given-names>G</given-names></name><name><surname>Grasso</surname><given-names>A</given-names></name><name><surname>Dahmane</surname><given-names>M</given-names></name></person-group><article-title>Role of ultrasonography in the staging of gastrointestinal neoplasms</article-title><source>Semin Surg Oncol</source><year>2001</year><volume>20</volume><fpage>86</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11398202</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polkowski</surname><given-names>M</given-names></name><name><surname>Palucki</surname><given-names>J</given-names></name><name><surname>Wronska</surname><given-names>E</given-names></name><name><surname>Szawlowski</surname><given-names>A</given-names></name><name><surname>Nasierowska-Guttmejer</surname><given-names>A</given-names></name><name><surname>Butruk</surname><given-names>E</given-names></name></person-group><article-title>Endosonography versus helical computed tomography for locoregional staging of gastric cancer</article-title><source>Endoscopy</source><year>2004</year><volume>36</volume><fpage>617</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">15243885</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsendsuren</surname><given-names>T</given-names></name><name><surname>Jun</surname><given-names>SM</given-names></name><name><surname>Mian</surname><given-names>XH</given-names></name></person-group><article-title>Usefulness of endoscopic ultrasonography in preoperative TNM staging of gastric cancer</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>43</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16440415</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>JS</given-names></name><name><surname>Noh</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Lymph node staging of gastric cancer using (18)F-FDG PET a comparison study with CT</article-title><source>J Nucl Med</source><year>2005</year><volume>46</volume><fpage>1582</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16204706</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>Y</given-names></name><name><surname>Imada</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>A</given-names></name><name><surname>Coit</surname><given-names>DG</given-names></name><name><surname>Brennan</surname><given-names>MF</given-names></name></person-group><article-title>Radical surgery for gastric cancer. A review of the Japanese experience</article-title><source>Cancer</source><year>1989</year><volume>64</volume><fpage>2053</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2680049</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lai</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Risk factors for lymph node metastasis in undifferentiated early gastric cancer</article-title><source>Ann Surg Oncol</source><year>2008</year><volume>15</volume><fpage>764</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18043971</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuernberg</surname><given-names>D</given-names></name><name><surname>Ignee</surname><given-names>A</given-names></name><name><surname>Dietrich</surname><given-names>CF</given-names></name></person-group><article-title>Current status of ultrasound in gastroenterology  bowel and upper gastrointestinal tract &#x02013; part 1</article-title><source>Z Gastroenterol</source><year>2007</year><volume>45</volume><fpage>629</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">17599290</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrt</surname><given-names>T</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><name><surname>Carlin</surname><given-names>JB</given-names></name></person-group><article-title>Bias prevalence and kappa</article-title><source>J Clin Epidemiol</source><year>1993</year><volume>46</volume><fpage>423</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8501467</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuschieri</surname><given-names>A</given-names></name><name><surname>Fayers</surname><given-names>P</given-names></name><name><surname>Fielding</surname><given-names>J</given-names></name><etal/></person-group><collab>The Surgical Cooperative Group</collab><article-title>Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer preliminary results of the MRC randomised controlled surgical trial</article-title><source>Lancet</source><year>1996</year><volume>347</volume><fpage>995</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8606613</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanebo</surname><given-names>HJ</given-names></name><name><surname>Kennedy</surname><given-names>BJ</given-names></name><name><surname>Winchester</surname><given-names>DP</given-names></name><name><surname>Fremgen</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>AK</given-names></name></person-group><article-title>Gastric carcinoma does lymph node dissection alter survival?</article-title><source>J Am Coll Surg</source><year>1996</year><volume>183</volume><fpage>616</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8957465</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuya</surname><given-names>T</given-names></name><name><surname>Honda</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Lymph-node metastases efficacy for detection with helical CT in patients with gastric cancer</article-title><source>Radiology</source><year>1995</year><volume>197</volume><fpage>705</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">7480743</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>H</given-names></name><name><surname>Maehara</surname><given-names>Y</given-names></name><name><surname>Okuyama</surname><given-names>T</given-names></name><etal/></person-group><article-title>Lymph node metastasis and macroscopic features in early gastric cancer</article-title><source>Hepatogastroenterology</source><year>1994</year><volume>41</volume><fpage>380</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7959576</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>N</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Otani</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Lymph node metastasis of early gastric cancer with submucosal invasion</article-title><source>Br J Surg</source><year>1998</year><volume>85</volume><fpage>835</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9667719</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahara</surname><given-names>K</given-names></name><name><surname>Tsuruta</surname><given-names>O</given-names></name><name><surname>Tateishi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Extended indication criteria for endoscopic mucosal resection of early gastric cancer with special reference to lymph node metastasis &#x02013; examination by multivariate analysis</article-title><source>Kurume Med J</source><year>2004</year><volume>51</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15150895</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monig</surname><given-names>SP</given-names></name><name><surname>Zirbes</surname><given-names>TK</given-names></name><name><surname>Schroder</surname><given-names>W</given-names></name><etal/></person-group><article-title>Staging of gastric cancer: correlation of lymph node size and metastatic infiltration</article-title><source>AJR Am J Roentgenol</source><year>1999</year><volume>173</volume><fpage>365</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10430138</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dworak</surname><given-names>O</given-names></name></person-group><article-title>Number and size of lymph nodes and node metastases in rectal carcinomas</article-title><source>Surg Endosc</source><year>1989</year><volume>3</volume><fpage>96</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2672395</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera-Ornelas</surname><given-names>L</given-names></name><name><surname>Justiniano</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>N</given-names></name><etal/></person-group><article-title>Metastases in small lymph nodes from colon cancer</article-title><source>Arch Surg</source><year>1987</year><volume>122</volume><fpage>1253</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3675188</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerr</surname><given-names>KM</given-names></name><name><surname>Lamb</surname><given-names>D</given-names></name><name><surname>Wathen</surname><given-names>CG</given-names></name><name><surname>Walker</surname><given-names>WS</given-names></name><name><surname>Douglas</surname><given-names>NJ</given-names></name></person-group><article-title>Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging</article-title><source>Thorax</source><year>1992</year><volume>47</volume><fpage>337</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">1609375</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotanagi</surname><given-names>H</given-names></name><name><surname>Fukuoka</surname><given-names>T</given-names></name><name><surname>Shibata</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer</article-title><source>J Surg Oncol</source><year>1993</year><volume>54</volume><fpage>252</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8255087</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>I</given-names></name><name><surname>Kokubo</surname><given-names>T</given-names></name><name><surname>Udagawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Mediastinal lymph node metastasis from esophageal carcinoma CT assessment with pathologic correlation</article-title><source>Nippon Igaku Hoshasen Gakkai Zasshi</source><year>1997</year><volume>57</volume><fpage>391</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">9232987</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwee</surname><given-names>RM</given-names></name><name><surname>Kwee</surname><given-names>TC</given-names></name></person-group><article-title>Predicting lymph node status in early gastric cancer</article-title><source>Gastric Cancer</source><year>2008</year><volume>11</volume><fpage>134</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">18825308</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>M</given-names></name></person-group><article-title>SonoVue a new ultrasound contrast agent</article-title><source>Eur Radiol</source><year>1999</year><volume>9</volume><issue>Suppl 3</issue><fpage>S347</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10602926</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Arditi</surname><given-names>M</given-names></name><name><surname>Barrau</surname><given-names>MB</given-names></name><etal/></person-group><article-title>BR1 a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles</article-title><source>Invest Radiol</source><year>1995</year><volume>30</volume><fpage>451</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8557510</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brasch</surname><given-names>RC</given-names></name><name><surname>Weinmann</surname><given-names>HJ</given-names></name><name><surname>Wesbey</surname><given-names>GE</given-names></name></person-group><article-title>Contrast-enhanced NMR imaging animal studies using gadolinium-DTPA complex</article-title><source>AJR Am J Roentgenol</source><year>1984</year><volume>142</volume><fpage>625</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">6607656</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strich</surname><given-names>G</given-names></name><name><surname>Hagan</surname><given-names>PL</given-names></name><name><surname>Gerber</surname><given-names>KH</given-names></name><name><surname>Slutsky</surname><given-names>RA</given-names></name></person-group><article-title>Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA</article-title><source>Radiology</source><year>1985</year><volume>154</volume><fpage>723</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3969477</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folkman</surname><given-names>J</given-names></name></person-group><article-title>What is the evidence that tumors are angiogenesis dependent?</article-title><source>J Natl Cancer Inst</source><year>1990</year><volume>82</volume><fpage>4</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">1688381</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folkman</surname><given-names>J</given-names></name><name><surname>Watson</surname><given-names>K</given-names></name><name><surname>Ingber</surname><given-names>D</given-names></name><name><surname>Hanahan</surname><given-names>D</given-names></name></person-group><article-title>Induction of angiogenesis during the transition from hyperplasia to neoplasia</article-title><source>Nature</source><year>1989</year><volume>339</volume><fpage>58</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">2469964</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>ZJ</given-names></name><name><surname>Gong</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>YE</given-names></name></person-group><article-title>Relationship between the expression of iNOS VEGF tumor angiogenesis and gastric cancer</article-title><source>World J Gastroenterol</source><year>2002</year><volume>8</volume><fpage>591</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12174362</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiangming</surname><given-names>C</given-names></name><name><surname>Hokita</surname><given-names>S</given-names></name><name><surname>Natsugoe</surname><given-names>S</given-names></name><etal/></person-group><article-title>Angiogenesis as an unfavorable factor related to lymph node metastasis in early gastric cancer</article-title><source>Ann Surg Oncol</source><year>1998</year><volume>5</volume><fpage>585</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9831105</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiyan</surname><given-names>L</given-names></name><name><surname>Pintong</surname><given-names>H</given-names></name><name><surname>Zongmin</surname><given-names>W</given-names></name><etal/></person-group><article-title>The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography</article-title><source>Ultrasound Med Biol</source><year>2009</year><volume>35</volume><fpage>1086</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">19419811</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Lymph node metastasis in early gastric cancer with submucosal invasion feasibility of minimally invasive surgery</article-title><source>World J Gastroenterol</source><year>2004</year><volume>10</volume><fpage>3549</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15534904</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiu</surname><given-names>MH</given-names></name><name><surname>Moore</surname><given-names>E</given-names></name><name><surname>Sanders</surname><given-names>M</given-names></name><etal/></person-group><article-title>Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multivariate analysis</article-title><source>Arch Surg</source><year>1987</year><volume>122</volume><fpage>1347</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">3675199</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Hasuike</surname><given-names>N</given-names></name><name><surname>Takizawa</surname><given-names>K</given-names></name></person-group><article-title>Endoscopic submucosal dissection of early gastric cancer</article-title><source>Digestion</source><year>2008</year><volume>77</volume><issue>Suppl 1</issue><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18204258</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukumura</surname><given-names>D</given-names></name><name><surname>Jain</surname><given-names>RK</given-names></name></person-group><article-title>Role of nitric oxide in angiogenesis and microcirculation in tumors</article-title><source>Cancer Metastasis Rev</source><year>1998</year><volume>17</volume><fpage>77</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">9544424</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmeliet</surname><given-names>P</given-names></name><name><surname>Jain</surname><given-names>RK</given-names></name></person-group><article-title>Angiogenesis in cancer and other diseases</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>249</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">11001068</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liekens</surname><given-names>S</given-names></name><name><surname>De Clercq</surname><given-names>E</given-names></name><name><surname>Neyts</surname><given-names>J</given-names></name></person-group><article-title>Angiogenesis: regulators and clinical applications</article-title><source>Biochem Pharmacol</source><year>2001</year><volume>61</volume><fpage>253</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11172729</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Gotanda</surname><given-names>T</given-names></name><name><surname>Uchimiya</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><fpage>1794</fpage><lpage>801</lpage><pub-id pub-id-type="pmid">14996742</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoda</surname><given-names>T</given-names></name><name><surname>Sasako</surname><given-names>M</given-names></name><name><surname>Ono</surname><given-names>H</given-names></name><name><surname>Katai</surname><given-names>H</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Shimoda</surname><given-names>T</given-names></name></person-group><article-title>Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer</article-title><source>Br J Surg</source><year>2001</year><volume>88</volume><fpage>444</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11260114</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>A case of EGC with LNM confirmed pathologically after operation. <bold>A:</bold> The early gastric cancer and LNM can not be detected with conventional transabdominal US. <bold>B:</bold> The early gastric cancer (white arrow) can be clearly demonstrated in the oral contrast-enhanced ultrasonography image, but LNM can not be demonstrated. <bold>C:</bold> Compared with the adjacent normal gastric wall (white arrow), marked hyperenhancement of the EGC (T) in DCUS image was shown during the early arterial phase</p><p>
<italic>STO &#x02013; stomach, T &#x02013; tumor, GB &#x02013; gallbladder, L &#x02013; live</italic>r</p></caption><graphic xlink:href="AMS-7-3-457_F1"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>A case of EGC without LNM confirmed pathologically after operation. <bold>A:</bold> The early gastric cancer and LNM could not be detected with conventional transabdominal US. <bold>B:</bold> The early gastric cancer (white arrow) and LNM (green arrow) can be clearly demonstrated in the oral contrast-enhanced ultrasonography image. <bold>C:</bold> Compared with the adjacent normal gastric wall (white arrow), unmarked hyperenhancement of the EGC (green arrow) in DCUS image was shown during the early arterialphase</p><p>
<italic>STO &#x02013; stomach, GB &#x02013; gallbladde</italic>r</p></caption><graphic xlink:href="AMS-7-3-457_F2"/></fig><table-wrap id="T1" position="float"><label>Table I</label><caption><p>The sensitivity, specificity, and Youden's index of oral contrast-enhanced ultrasonography (CEUS) and double contrast-enhanced ultra - sonography (DCUS) in detecting lymph node metastasis</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Sensitivity [%]</th><th rowspan="1" colspan="1">Specificity [%]</th><th rowspan="1" colspan="1">Youden's index</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>Oral CEUS</bold></td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">98.4</td><td align="center" rowspan="1" colspan="1">0.317</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>DCUS</bold></td><td align="center" rowspan="1" colspan="1">86.7</td><td align="center" rowspan="1" colspan="1">60.7</td><td align="center" rowspan="1" colspan="1">0.474</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table II</label><caption><p>The relationship between different clinicopathological characteristics and the rate of lymph node metastasis as well as the contrast-enhanced intensity</p></caption><table frame="border" rules="rows" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Factors</th><th rowspan="1" colspan="1">Node negative</th><th rowspan="1" colspan="1">Node positive</th><th rowspan="1" colspan="1">Value of <italic>p</italic></th><th rowspan="1" colspan="1">Marked hyperenhancement</th><th rowspan="1" colspan="1">Unmarked hyperenhancement</th><th rowspan="1" colspan="1">Value of p</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age [years]</td><td align="center" rowspan="1" colspan="1">61.0 &#x000b1;13.5</td><td align="center" rowspan="1" colspan="1">57.7 &#x000b1;10.3</td><td align="center" rowspan="1" colspan="1">0.382</td><td align="center" rowspan="1" colspan="1">58.5 &#x000b1;10.9</td><td align="center" rowspan="1" colspan="1">58.2 &#x000b1;11.1</td><td align="center" rowspan="1" colspan="1">0.887</td></tr><tr><td rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="2" valign="top" colspan="1">0.777</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="2" valign="top" colspan="1">0.260</td></tr><tr><td rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td rowspan="1" colspan="1">Upper</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="3" valign="top" colspan="1">0.291</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="3" valign="top" colspan="1">0.446</td></tr><tr><td rowspan="1" colspan="1">Middle</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td rowspan="1" colspan="1">Lower</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">30</td></tr><tr><td rowspan="1" colspan="1">Tumor diameter [mm]</td><td align="center" rowspan="1" colspan="1">31.4 &#x000b1;9.6</td><td align="center" rowspan="1" colspan="1">30.8 &#x000b1;12.0</td><td align="center" rowspan="1" colspan="1">0.866</td><td align="center" rowspan="1" colspan="1">35.4 &#x000b1;13.1</td><td align="center" rowspan="1" colspan="1">26.8 &#x000b1;7.80</td><td align="center" valign="top" rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">Mucosa</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="2" valign="top" colspan="1">0.073</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="2" valign="top" colspan="1">0.105</td></tr><tr><td rowspan="1" colspan="1">Submucosa</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td rowspan="1" colspan="1"><bold>Histological type:</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Differentiated</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="2" valign="top" colspan="1">0.032</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="2" valign="top" colspan="1">0.012</td></tr><tr><td rowspan="1" colspan="1">Undifferentiated</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">11</td></tr></tbody></table></table-wrap></floats-group></article>